Cargando…

SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

PURPOSE: A nonsynonymous coding variant in the manganese superoxide dismutase (SOD2) gene (V16A, rs4880) has been implicated in neovascular age-related macular degeneration (AMD). However, the findings have been inconsistent. Two studies in Japanese populations reported an opposite direction of asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Naoshi, Bessho, Hiroaki, Honda, Shigeru, Negi, Akira
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2742636/
https://www.ncbi.nlm.nih.gov/pubmed/19753309
_version_ 1782171834486095872
author Kondo, Naoshi
Bessho, Hiroaki
Honda, Shigeru
Negi, Akira
author_facet Kondo, Naoshi
Bessho, Hiroaki
Honda, Shigeru
Negi, Akira
author_sort Kondo, Naoshi
collection PubMed
description PURPOSE: A nonsynonymous coding variant in the manganese superoxide dismutase (SOD2) gene (V16A, rs4880) has been implicated in neovascular age-related macular degeneration (AMD). However, the findings have been inconsistent. Two studies in Japanese populations reported an opposite direction of association of the same allele at the V16A variant, whereas one study in a Northern Irish population found no effect of the variant on the risk of developing neovascular AMD. To address these apparently contradictory reports, we validated the association in a Japanese population. METHODS: In a Japanese population, we genotyped the V16A variant in 116 neovascular AMD patients, 140 polypoidal choroidal vasculopathy (PCV) patients, and 189 control participants. This association was also tested in a population of PCV participants to avoid variable findings across studies due to underlying sample heterogeneity and because disease phenotype was not well described in previous studies. We analyzed a tagging single nucleotide polymorphism (SNP) in addition to the V16A variant to capture all common SOD2 variations verified by the HapMap project. Genotyping was conducted using TaqMan technology. Associations were tested using single-SNP and haplotype analyses as well as a meta-analysis of the published literature. Population stratification was also evaluated in our study population. RESULTS: We found no detectable association of the V16A variant or any other common SOD2 variation with either neovascular AMD or PCV, as demonstrated by both single-SNP and haplotype analyses. Population structure analyses precluded stratification artifacts in our study cohort. A meta-analysis of the association between the V16A variant and neovascular AMD also failed to detect a significant association. CONCLUSIONS: We found no evidence to support the role of any common SOD2 variations including the V16A variant in the susceptibility to neovascular AMD or PCV. Our study highlights the importance and difficulty in replicating genetic association studies of complex human diseases.
format Text
id pubmed-2742636
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-27426362009-09-14 SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy Kondo, Naoshi Bessho, Hiroaki Honda, Shigeru Negi, Akira Mol Vis Research Article PURPOSE: A nonsynonymous coding variant in the manganese superoxide dismutase (SOD2) gene (V16A, rs4880) has been implicated in neovascular age-related macular degeneration (AMD). However, the findings have been inconsistent. Two studies in Japanese populations reported an opposite direction of association of the same allele at the V16A variant, whereas one study in a Northern Irish population found no effect of the variant on the risk of developing neovascular AMD. To address these apparently contradictory reports, we validated the association in a Japanese population. METHODS: In a Japanese population, we genotyped the V16A variant in 116 neovascular AMD patients, 140 polypoidal choroidal vasculopathy (PCV) patients, and 189 control participants. This association was also tested in a population of PCV participants to avoid variable findings across studies due to underlying sample heterogeneity and because disease phenotype was not well described in previous studies. We analyzed a tagging single nucleotide polymorphism (SNP) in addition to the V16A variant to capture all common SOD2 variations verified by the HapMap project. Genotyping was conducted using TaqMan technology. Associations were tested using single-SNP and haplotype analyses as well as a meta-analysis of the published literature. Population stratification was also evaluated in our study population. RESULTS: We found no detectable association of the V16A variant or any other common SOD2 variation with either neovascular AMD or PCV, as demonstrated by both single-SNP and haplotype analyses. Population structure analyses precluded stratification artifacts in our study cohort. A meta-analysis of the association between the V16A variant and neovascular AMD also failed to detect a significant association. CONCLUSIONS: We found no evidence to support the role of any common SOD2 variations including the V16A variant in the susceptibility to neovascular AMD or PCV. Our study highlights the importance and difficulty in replicating genetic association studies of complex human diseases. Molecular Vision 2009-09-09 /pmc/articles/PMC2742636/ /pubmed/19753309 Text en http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kondo, Naoshi
Bessho, Hiroaki
Honda, Shigeru
Negi, Akira
SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
title SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
title_full SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
title_fullStr SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
title_full_unstemmed SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
title_short SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
title_sort sod2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2742636/
https://www.ncbi.nlm.nih.gov/pubmed/19753309
work_keys_str_mv AT kondonaoshi sod2genepolymorphismsinneovascularagerelatedmaculardegenerationandpolypoidalchoroidalvasculopathy
AT besshohiroaki sod2genepolymorphismsinneovascularagerelatedmaculardegenerationandpolypoidalchoroidalvasculopathy
AT hondashigeru sod2genepolymorphismsinneovascularagerelatedmaculardegenerationandpolypoidalchoroidalvasculopathy
AT negiakira sod2genepolymorphismsinneovascularagerelatedmaculardegenerationandpolypoidalchoroidalvasculopathy